Obstructive Lung Diseases (L17-18) Flashcards

1
Q

When might respiratory failure occur?

2

A

When there is:

  • Impaired Clearance of CO2 from the Lungs
  • Impaired Absorption of O2 from the Air
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe Type I Respiratory Failure/Acute Hypoxaemic Respiratory Failure.

A
  • Caused by a ventilation/perfusion mismatch
  1. Arterial pO2 is low
  2. Arterial pCO2 is normal or low
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Type I Respiratory Failure occurs with diseases that damage the lung.
Name them.

A
  • Low ambient oxygen (high altitude)
  • Pneumonia (parenchymal disease)
  • Pulmonary Fibrosis
  • Ventilation/Perfusion mismatch (pulmonary embolism)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe Type II Respiratory Failure

A
  • Caused by increased airway resistance due to reduced breathing effort, increased resistance to breathing or a decrease in the lung area available for gas exchange.
  1. Arterial pO2 is low
  2. pCO2 is high (Hypercapnia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List the most common causes of Type II Respiratory Failure.

A
  • COPD
  • Asthma
  • Poliomyelitis
  • Drug overdose
  • Myasthenia gravis
  • Motor neuron disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define Obstructive Lung Disease.

A

A decrease in the exhaled air flow caused by acute or chronic narrowing or blockage of the airways causing increased resistance to airflow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define Restrictive Lung Disease.

A

A decrease in the total volume of air that the lungs are able to hold. Often this is due to a decrease in the elasticity of the lungs or a problem related to the expansion of the chest wall during inhalation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the predominant cause of COPD?

A

Smoking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

COPD Pathology:

Central Airways:
Bronchial gland hypertrophy and goblet cell metaplasia – results in excessive ___1___ production (chronic bronchitis).
___2___ metaplasia of airway epithelium, loss of cilia and cilia dysfunction, increased smooth muscle and connective tissue.

Peripheral Airways:
Bronchiolitis at an early stage. Pathological extension of goblet cells and ___2___ metaplasia in the peripheral airways. As the disease progresses there is fibrosis and increased deposition of ___3___.

Pulmonay Vasculature:
Pulmonary vasculature changes begin early in disease. Initially characterised by ___4___ of the vessel wall and endothelial cell dysfunction.
Followed by increased smooth muscle, infiltration of inflammatory cells and in advanced disease there is ___3___ deposition and destruction of the capillary bed.

A
  1. Mucus
  2. Squamous
  3. Collagen
  4. Thickening
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

COPD is characterized by an increase in ___1___, macrophages, and T lymphocytes (especially ___2___) in various parts of the lung.
There may also be an increase in eosinophils in some patients, particularly during exacerbations.
These increases are brought about by increases in inflammatory cell recruitment, ___3___, and/or activation.
Many studies reveal a correlation between the number of inflammatory cells of various types in the lung and the severity of COPD.

A
  1. Neutrophils
  2. CD8+
  3. Survival
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the Inflammatory Cell Increases in COPD in the following:

Large Airways.

Small Airways.

Parenchyma.

Pulmonary Arteries.

A

Large Airways:

  • Macrophages
  • T lymphocytes (especially CD8+)
  • Neutrophils (severe disease only)
  • Eosinophils (in some patients)

Small Airways:

  • Macrophages
  • T lymphocytes (especially CD8+)
  • Eosinophils (in some patients)

Parenchyma:

  • Macrophages
  • T lymphocytes (especially CD8+)
  • Neutrophils (severe disease only)

Pulmonary Arteries:

  • T lymphocytes (especially CD8+)
  • Neutrophils (severe disease only)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Inflammation is present in the lungs of ___1___ without a diagnosis of COPD. This inflammation is similar to, but less intense than, the inflammation in the lungs of patients with COPD. Thus, the inflammation characteristic of COPD is thought to represent an ___2___ of a normal, protective response to inhalational exposures.

A
  1. Smokers

2. Exaggeration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List the most common symptoms of COPD.

A
  • Exertional Breathlessness
  • Chronic Cough
  • Regular Sputum production
  • Frequent winter bronchitis
  • Wheeze

They may also show:

  • Weight loss
  • Effort intolerance
  • Waking at night
  • Ankle swelling
  • General fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The MRC dyspnoea scale is used to grade breathlessness.

Describe it from grade 1 (least severe) to grade 5 (most severe).

A

Grade 1: Not troubled by breathlessness except on strenuous exercise

Grade 2: Short of breath when hurrying or walking up a slight hill

Grade 3: Walks slower than contemporaries on level ground because of breathlessness, or has to stop for breath when walking at own pace.

Grade 4. Stops for breath after walking about 100 metres or after a few minutes on level ground.

Grade 5. To breathless to leave the house, or breathless when dressing, undressing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is used to treat stable COPD?

4

A
  • Bronchodilators
  • Corticosteroids
  • Mucolytics
  • Antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clinically define Chronic Bronchitis.

A

A cough productive of sputum on most days for three months of the year for at least two consecutive years.

17
Q

What is the major consequence of chronic bronchitis?

A

Airway obstruction.

18
Q

What does Chronic Bronchitis lead to?

4

A
  • Alveolar Hypoventilation
  • Hypoxaemia
  • Hypercapnia
  • Type II Respiratory Failure
19
Q

Define Emphysema.

A

Permanent enlargement (dilation) of any part of the respiratory acinus (air spaces distal to the terminal bronchiole) with destruction of their walls (without scarring).

20
Q

Name the 2 main patterns of Emphysema.

Describe each.

A

Centriacinar (centrilobular)
- Is a result of the destruction of the respiratory bronchioles.

Panacinar (panlobular)
- Results from a more uniform destruction of all of the acinis and particularly affects the lower lungs.

21
Q

The main Emphysema pathogenesis theory is:
The proteinase-antiproteinase hypothesis.

Describe it.

A

Destruction of alveoli occurs due to the un-regulated activity of proteinase enzymes.

It is due to an imbalance of protease and the protease inhibitor a1-antitrypsin. Proteases (particularly Neutrophil Elastase) cause the breakdown of alveolar walls and collapse of small airways.

22
Q

Alpha -1 antitrypsin deficiency (AATD) is thought to be one of the most common genetic deficiencies in ___1___.

There are many different mutations in AAT but the most severe type is commonest in North West Europe. It occurs with a frequency of 1/___2___ in Scandinavia.

The most common form allele in the European population is M and two mutant alleles S and ___3___ account for most of the disease.

A
  1. Caucasians
  2. 1600
  3. Z
23
Q

What is the classic presentation of patients with Emphysema?

A

Barrel-chested and dyspnoeic.

24
Q

The loss of elastic recoil and structural support due to Emphysema leads to what?
(3)

A
  • Trapping of air in lungs
  • Over inflated lungs
  • Decreased rate of airflow on expiration
25
Q

Cyanosis, hypercapnia and cor pulmonale (enlargement of the right ventricle) occur _____ in Emphysema after progressive decline in lung function.

A

Late.

26
Q

Individuals with emphysema have reduced oxygen uptake despite an increase in ventilation.

Although they manage to maintain blood oxygenation by rapid respiration they feel breathless on the slightest exertion and become hypoxic (Type II respiratory failure).

Patients are known as ‘_____ _____’

A

Pink Puffers.

27
Q

Describe the pathology of Asthma.
(5)

This leads to?

A
  • Mucosal Oedema
  • Inflammatory cell infiltration (Eosinophils 5%-50%)
  • Basement membrane thickening
  • Goblet cell and submucosal gland hyperplasia.
  • Hypertrophy and hyperplasia of the smooth muscle in the bronchial wall.
  • Airway Obstruction
  • Bronchial Muscle Constriction
  • Airway Congestion
28
Q

In Asthma thick mucus plugs can block the bronchi and bronchioles.
What do the mucus plugs contain?

A
  • Whorls of shed epithelium
  • Eosinophils
  • Charcot - Leyden Crystals
29
Q

Asthma is split into extrinsic and intrinsic asthma which is based on its cause.

Describe each type.

A

Extrinsic (allergic) asthma
- Caused by Type I hypersensitivity reactions on exposure to extrinsic allergen

Intrinsic asthma
- Non-immune trigger mechanism e.g. cold, stress, exercise, inhaled irritants (gases)

30
Q

Describe Obliterative bronchiolitis.

A

Obliterative bronchiolitis (OB) is an irreversible lung disease that occurs in children and adults after injury to the lower respiratory tract. There is concentric narrowing and distortion of the bronchiole walls caused by inflammation and fibrosis. The alveoli are not involved.

31
Q

Describe Non-smoking fixed obstruction.

A

There is evidence that in some non-smoking patients with asthma remodelling may occur that may finally result in fixed lung obstruction.

32
Q

Describe Viral wheeze.

A

Episodic attacks of wheeze triggered by viral colds are common in children aged between 1 and 5 years.

33
Q

Describe Allergic bronchopulmonary aspergillosis.

A

A hypersensitivity response to the fungus Aspergillus fumigatus. The subsequent damage to the bronchial wall causes (proximal) bronchiectasis. Repeated acute episodes left untreated can result in progressive pulmonary fibrosis.

34
Q

Describe Bronchiectasis.

A

Localized, irreversible dilation of part of the bronchial tree. Bronchi are dilated, inflamed, and easily collapsible, resulting in airflow obstruction and impaired clearance of secretions. Normally a result of infection.